Improving access to our anticancer product in India
Collaborating with local partners to improve access to our anticancer product in India.


SEE ALL PARTNER ORGANIZATIONS
Objectives
- Increase the number of patients able to access our anticancer product in India.
What are the health needs and challenges?
With changes in lifestyle-related behavior, the incidence rate of prostate cancer is constantly and rapidly increasing in India. Some cancer projection data show that the number of cases will double by 2020 (as compared to 2012).
In India, most patients have to pay the full cost of purchasing prescription.
Partnership activities and how they address needs and challenges
Astellas is introducing a new program structured according to patients’ income levels to improve patients’ access to our anticancer product in India, in collaboration with local partners. It is believed that this new program will increase the number of patients able to access our product in India. Astellas recognizes that the affordability of medicines is one aspect impacting patients’ Access to Health. We will continue exploring various solutions which improve patients’ access to our products.
Geographic Reach
- South-East Asia
Disease Area
- Non-communicable Diseases
SGDs the partnership contributes to
- 3.4: NCDs (including mental health)
- 3.8: Achieve universal health coverage
Partner organizations
Geographic Reach
South-East Asia
- India
Disease Area
Non-communicable Diseases
- Cancer